The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases

Overview of attention for article published in Nature Reviews Immunology, April 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 2 news outlets
twitter: 9 X users
patent: 16 patents

facebook: 18 Facebook pages
wikipedia: 1 Wikipedia page
f1000: 1 research highlight platform

Readers on

mendeley: 451 Mendeley
citeulike: 1 CiteULike

Summary News X Patents Facebook Wikipedia Research highlights

So far, Altmetric has seen 2 news stories from 2 outlets.

Could Immunotherapy Treat Diseases Besides Cancer?

Scientific American, 30 Sep 2019

Immunotherapy has transformed cancer care. Now the tools and new knowledge created by this strategy for treating disease by…

The promise of lowdose interleukin2 therapy for autoimmune and inflammatory diseases

Bioportfolio, 17 Apr 2015

The dominant role of interleukin2 IL2 is in the maintenance of regulatory T cells rather than of effector T cells. This has led…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.